Characteristics of Kawasaki disease in infants younger than six months of age

Pediatric Infectious Disease Journal

Volumn 25, Issue 3, 2006, Pages 241-244

  Chang, Feng Yu ^a   Hwang, Betau ^a   Chen, Sue Jean ^a   Lee, Pi Chang ^a,b   Meng, C C Laura ^a   Lu, Jen Her ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Coronary involvement; Infants; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; HEMOGLOBIN; IMMUNOGLOBULIN; TRIACYLGLYCEROL;

ANTICOAGULATION; ARTICLE; CHILDHOOD; CLINICAL FEATURE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HYDROPS; INFANT; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; THERAPY DELAY; THROMBOCYTE COUNT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

AGE FACTORS; AGE OF ONSET; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INCIDENCE; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; TREATMENT OUTCOME;

EID: 33644926179     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000202067.50975.90     Document Type: Article

References (21)

1. Tseng CF, Fu YC, Fu LS, Betau H, Chi CS. Clinical spectrum of Kawasaki disease in infants. Zhonghua Yi Xue Za Zhi (Taipei). 2001; 64:168-173.
2. Burns JC, Wiggins JW Jr, Toews WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr. 1986;109:759-763.
3. Council on Cardiovascular Disease in the Young, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, American Heart Association. Diagnostic guidelines for Kawasaki disease. Circulation. 2001;103:335-336.
4. Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr. 1987;110:409-413.
5. Levy M, Koren G. Atypical Kawasaki disease: Analysis of clinical presentation and diagnostic clues. Pediatr Infect Dis J. 1990;9:122-126.
6. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulins as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633-1639.
7. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on cardiovascular disease in the young, American Heart Association. Pediatrics. 2004;114:1708-1733.
8. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102:e65.
9. Yanagawa H, Nakamura Y, Ojima T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107:e33.
10. Yanagawa H, Yashiro M, Nakamura Y, et al. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992. Pediatrics. 1995;95:475-479.
11. Lue HC, Philip S, Chen MR, et al. Surveillance of Kawasaki disease in Taiwan and review of the literature. Acta Pediatr Taiwan. 2004;45: 8-14.
12. Chang RK. Hospitalizations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics. 2002;109:e87.
13. Abe J, Kotzin BL, Jujo K, et al. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA. 1992;89:4066-4070.
14. Abe J, Kotzin BL, Meissner C, et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 1993;177:791-76.
15. Pietra BA, de Inocencio J, Giannini EH, et al. T cell receptor Vβfamily repertoire and T cell activation markers in Kawasaki disease. J Immunol. 1994;153:1881-1888.
16. Hou JW, Chang MH, Wu MH, Lee CY. Kawasaki disease complicated by gallbladder hydrops mimicking acute abdomen: a report of three cases. Acta Pediatr Taiwan. 1989;30:52-60.
17. Cheung YF, Yung TC, Tam SC, et al. Novel and traditional cardiovascular risk factors in children after Kawasaki disease. J Am Coll Cardiol. 2004;43:120-124.
18. Wilson N, Heaton P, Calder L, et al. Kawasaki disease with severe cardiac sequelae: Lessons from recent New Zealand experience. J Pediatr Child Health. 2004;40:524-529.
19. Anderson MS, Todd JK, Glodé MP, et al. Delayed diagnosis of Kawasaki Syndrome: An analysis of the problem. Pediatrics. 2005;115: 428-433.
20. Yanagawa H, Yashiro M, Nakamura Y, et al. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch Pediatr Adolesc Med. 1995;149:779-783.
21. Yosikazu N, Izumi O, et al. Cardiac sequelae in recurrent cases of Kawasaki Disease: A comparison between the initial episode of the disease and a recurrence in the same patients. Pediatrics. 1998;102: e66.